在诊所进行舌下免疫疗法的讨论

Q4 Medicine Practica Otologica Pub Date : 2023-01-01 DOI:10.5631/jibirin.116.947

Satoru Masuno

{"title":"在诊所进行舌下免疫疗法的讨论","authors":"Satoru Masuno","doi":"10.5631/jibirin.116.947","DOIUrl":null,"url":null,"abstract":"Background: Allergen immunotherapy is the only curative treatment for allergic rhinitis (AR) that can induce long-term clinical remission. In Japan, sublingual immunotherapy (SLIT) is often employed for the treatment of AR caused by Japanese cedar pollen (JCP) and house dust mites (HDM). To obtain a high likelihood for remission, SLIT should be continued for at least 3 to 5 years; however, a substantial number of patients dropout from the treatment.","PeriodicalId":52493,"journal":{"name":"Practica Otologica","volume":"42 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"診療所における舌下免疫療法の検討\",\"authors\":\"Satoru Masuno\",\"doi\":\"10.5631/jibirin.116.947\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: Allergen immunotherapy is the only curative treatment for allergic rhinitis (AR) that can induce long-term clinical remission. In Japan, sublingual immunotherapy (SLIT) is often employed for the treatment of AR caused by Japanese cedar pollen (JCP) and house dust mites (HDM). To obtain a high likelihood for remission, SLIT should be continued for at least 3 to 5 years; however, a substantial number of patients dropout from the treatment.\",\"PeriodicalId\":52493,\"journal\":{\"name\":\"Practica Otologica\",\"volume\":\"42 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Practica Otologica\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5631/jibirin.116.947\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Practica Otologica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5631/jibirin.116.947","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

摘要

背景:过敏原免疫疗法是治疗变应性鼻炎(AR)唯一能引起长期临床缓解的治疗方法。在日本，舌下免疫疗法(SLIT)常用于治疗由杉木花粉(JCP)和屋尘螨(HDM)引起的AR。为了获得较高的缓解可能性，SLIT应至少持续3至5年;然而，相当数量的患者退出了治疗。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

診療所における舌下免疫療法の検討

Background: Allergen immunotherapy is the only curative treatment for allergic rhinitis (AR) that can induce long-term clinical remission. In Japan, sublingual immunotherapy (SLIT) is often employed for the treatment of AR caused by Japanese cedar pollen (JCP) and house dust mites (HDM). To obtain a high likelihood for remission, SLIT should be continued for at least 3 to 5 years; however, a substantial number of patients dropout from the treatment.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Practica Otologica Medicine-Otorhinolaryngology

自引率

0.00%

发文量